Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Stomach Neoplasms/drug therapy"'
Publikováno v:
Arquivos de Gastroenterologia, Vol 58, Iss 1, Pp 26-31 (2021)
ABSTRACT BACKGROUND: Worldwide, colorectal cancer (CRC) and gastric cancer (GC) are the third and the fifth most prevalent, respectively. Diarrhea is a common symptom in patients on chemotherapy or radiotherapy treatment and can reduce treatment tole
Externí odkaz:
https://doaj.org/article/da8c3fcd28d44a61b0b8875c24755691
Autor:
Michael Vieth, Luca Mastracci, Lars Lundell, Andrianos Tsekrekos, Jean François Fléjou, Sönke Detlefsen, Kieran Sheahan, Adrian C Bateman, Nelson Ndegwa, Rhonda K. Yantiss, Heike I. Grabsch, Jayant Shetye, Luca Saragoni, Sybren L. Meijer
Publikováno v:
Human Pathology, 116, 94-101. W B Saunders Co-Elsevier Inc
Tsekrekos, A, Vieth, M, Ndegwa, N, Bateman, A, Flejou, J-F, Grabsch, H I, Mastracci, L, Meijer, S L, Saragoni, L, Sheahan, K, Shetye, J, Yantiss, R, Lundell, L & Detlefsen, S 2021, ' Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes ', Human Pathology, vol. 116, pp. 94-101 . https://doi.org/10.1016/j.humpath.2021.07.003
Human pathology, 116, 94-101. W.B. Saunders Ltd
Tsekrekos, A, Vieth, M, Ndegwa, N, Bateman, A, Flejou, J-F, Grabsch, H I, Mastracci, L, Meijer, S L, Saragoni, L, Sheahan, K, Shetye, J, Yantiss, R, Lundell, L & Detlefsen, S 2021, ' Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes ', Human Pathology, vol. 116, pp. 94-101 . https://doi.org/10.1016/j.humpath.2021.07.003
Human pathology, 116, 94-101. W.B. Saunders Ltd
Perioperative chemotherapy is increasingly used in combination with surgery for the treatment of patients with locally advanced, resectable gastric cancer. Histologic tumor regression grade (TRG) has emerged as an important prognostic factor; however
Autor:
Oshima, Takashi, Tsuburaya, Akira, Yoshida, Kazuhiro, Yoshikawa, Takaki, Miyagi, Yohei, Rino, Yasushi, Masuda, Munetaka, Guan, Jia, Tan, Patrick, Grabsch, Heike I, Sakamoto, Junichi, Tanaka, Shiro
Publikováno v:
Scientific Reports, 12(1):8509. Nature Publishing Group
Biomarkers for selecting gastric cancer (GC) patients likely to benefit from sequential paclitaxel treatment followed by fluorinated-pyrimidine-based adjuvant chemotherapy (sequential paclitaxel) were investigated using tissue samples of patients rec
Publikováno v:
Arquivos de Gastroenterologia v.58 n.1 2021
Arquivos de gastroenterologia
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia
instacron:IBEPEGE
Arquivos de Gastroenterologia, Vol 58, Iss 1, Pp 26-31 (2021)
Arquivos de gastroenterologia
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia
instacron:IBEPEGE
Arquivos de Gastroenterologia, Vol 58, Iss 1, Pp 26-31 (2021)
BACKGROUND: Worldwide, colorectal cancer (CRC) and gastric cancer (GC) are the third and the fifth most prevalent, respectively. Diarrhea is a common symptom in patients on chemotherapy or radiotherapy treatment and can reduce treatment tolerance. Su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::155359a92e09b2ac6b56733de7a6fdad
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032021000100026
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032021000100026
Publikováno v:
Der Chirurg, Vol. 92, No 6 (2021) pp. 515-521
Zusammenfassung: HINTERGRUND: Zum Zeitpunkt der Diagnosestellung des Magenkarzinoms haben ca. zwei Drittel der Patienten bereits Metastasen. Wichtig ist es, die Oligometastasierung von der diffus metastasierten Situation abzugrenzen. Die S3-Leitlinie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1400::40e9e341031bf7cafcf7c7ca05717b9f
https://archive-ouverte.unige.ch/unige:158685
https://archive-ouverte.unige.ch/unige:158685
Autor:
Charlotte Maggen, Elyce Cardonick, Michael J. Halaska, Mathilde van Gerwen, Martin Koskas, Petronella B. Ottevanger, Robert Fruscio, Christianne A.R. Lok, Ingrid A. Boere, Kristel Van Calsteren, Frédéric Amant, Petronella O. Witteveen, Mina Mhallem Gziri
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica, 99, 79-88
Acta Obstetricia et Gynecologica Scandinavica, 99(1), 79. Wiley-Blackwell
Acta Obstetricia et Gynecologica Scandinavica, 99, 1, pp. 79-88
Acta obstetricia et gynecologica Scandinavica, 99(1), 79-88. Wiley-Blackwell
Acta Obstetricia et Gynecologica Scandinavica, 99, 79-88. Wiley-Blackwell
Acta Obstetricia et Gynecologica Scandinavica
Acta obstetricia et gynecologica Scandinavica, Vol. 99, no. 1, p. 79-88 (2020)
Acta Obstetricia et Gynecologica Scandinavica, 99(1), 79. Wiley-Blackwell
Acta Obstetricia et Gynecologica Scandinavica, 99, 1, pp. 79-88
Acta obstetricia et gynecologica Scandinavica, 99(1), 79-88. Wiley-Blackwell
Acta Obstetricia et Gynecologica Scandinavica, 99, 79-88. Wiley-Blackwell
Acta Obstetricia et Gynecologica Scandinavica
Acta obstetricia et gynecologica Scandinavica, Vol. 99, no. 1, p. 79-88 (2020)
INTRODUCTION: Gastric cancer during pregnancy is extremely rare and data on optimal treatment and possible chemotherapeutic regimens are scarce. The aim of this study is to describe the obstetric and maternal outcome of women with gastric cancer duri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2988e65a7760b261d452eceaeb630d36
http://hdl.handle.net/10281/244028
http://hdl.handle.net/10281/244028
Autor:
Melika HASSANI, Nasrin GHASSEMI-BARGHI, Mona MODANLOO, Abbas MOHAMMADPOUR, Mohammad SHOKRZADEH
Publikováno v:
Arquivos de Gastroenterologia, Volume: 56, Issue: 4, Pages: 372-376, Published: 07 NOV 2019
Arquivos de Gastroenterologia
Arquivos de Gastroenterologia, Issue: ahead, Published: 07 NOV 2019
Arquivos de Gastroenterologia v.56 n.4 2019
Arquivos de gastroenterologia
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia
instacron:IBEPEGE
Arquivos de Gastroenterologia
Arquivos de Gastroenterologia, Issue: ahead, Published: 07 NOV 2019
Arquivos de Gastroenterologia v.56 n.4 2019
Arquivos de gastroenterologia
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia
instacron:IBEPEGE
BACKGROUND: Gastric cancer is the second leading cause of cancer-related death globally. Unfortunately, the survival rate of the gastric cancer patients who underwent chemotherapy following surgery has been less than a half. Besides, chemotherapy has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01e6fd6ef1ad2a3d9054648e97c998aa
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032019000400372&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032019000400372&lng=en&tlng=en
Autor:
Al-Batran, Salah-Eddin, Homann, Nils, Pauligk, Claudia, Goetze, Thorsten O, Meiler, Johannes, Kasper, Stefan, Kopp, Hans-Georg, Mayer, Frank, Haag, Georg Martin, Luley, Kim, Lindig, Udo, Schmiegel, Wolff, Pohl, Michael, Stoehlmacher, Jan, Folprecht, Gunnar, Probst, Stephan, Prasnikar, Nicole, Fischbach, Wolfgang, Mahlberg, Rolf, Trojan, Jörg, Koenigsmann, Michael, Martens, Uwe M, Thuss-Patience, Peter, Egger, Matthias, Block, Andreas, Heinemann, Volker, Illerhaus, Gerald, Moehler, Markus, Schenk, Michael, Kullmann, Frank, Behringer, Dirk M, Heike, Michael, Pink, Daniel, Teschendorf, Christian, Löhr, Carmen, Bernhard, Helga, Schuch, Gunter, Rethwisch, Volker, von Weikersthal, Ludwig Fischer, Hartmann, Jörg T, Kneba, Michael, Daum, Severin, Schulmann, Karsten, Weniger, Jörg, Belle, Sebastian, Gaiser, Timo, Oduncu, Fuat S, Güntner, Martina, Hozaeel, Wael, Reichart, Alexander, Jäger, Elke, Kraus, Thomas, Moenig, Stefan Paul, Bechstein, Wolf O, Schuler, Martin, Schmalenberg, Harald, Hofheinz, Ralf D, FLOT4-AIO Investigators
Publikováno v:
The Lancet, Vol. 393, No 10184 (2019) pp. 1948-1957
Docetaxel-based chemotherapy is effective in metastatic gastric and gastro-oesophageal junction adenocarcinoma. This study reports on the safety and efficacy of the docetaxel-based triplet FLOT (fluorouracil plus leucovorin, oxaliplatin and docetaxel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1400::0b9cf264bfe92e55766adcd35c21e6e4
https://archive-ouverte.unige.ch/unige:134616
https://archive-ouverte.unige.ch/unige:134616
Autor:
Meritxell Balmaña, Francisca Diniz, Tália Feijão, Celso A. Reis, Stefan Mereiter, Cristina C. Barrias
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 21; Issue 3; Pages: 722
International Journal of Molecular Sciences, Vol 21, Iss 3, p 722 (2020)
International Journal of Molecular Sciences; Volume 21; Issue 3; Pages: 722
International Journal of Molecular Sciences, Vol 21, Iss 3, p 722 (2020)
In the scenario of personalized medicine, targeted therapies are currently the focus of cancer drug development. These drugs can block the growth and spread of tumor cells by interfering with key molecules involved in malignancy, such as receptor tyr
Autor:
Magdalena Jadwiga Utsch, Anna Krilova, Özlem Türeci, Martin Schuler, Karl Dhaene, Markus Jerling, Christoph Rohde, Stefan Bauer, Tobias Dechow, Ugur Sahin, Heike Richly, Christoph Huber
Introduction IMAB362 (Zolbetuximab) is a chimeric monoclonal antibody that binds to Claudin-18.2, a target antigen specific to cancer cells. In vitro, IMAB362 mediates cell death through antibody-dependent cellular cytotoxicity and complement-depende
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdb9949f013111d7e7dd98d889459c98
https://doi.org/10.1016/j.ejca.2018.05.007
https://doi.org/10.1016/j.ejca.2018.05.007